📄 Summary
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of June 24, 2026. That notice opened a public docket to solicit input and comments on a proposal to establish a pilot program, the Expedited Investigational New Drug pilot program, to shorten the time it takes from drug identification to first-in-human study, while protecting clinical trial participants. FDA is correcting the email address of the document.
